It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Oxidative stress-induced lipid accumulation is mediated by lipid droplets (LDs) homeostasis, which sequester vulnerable unsaturated triglycerides into LDs to prevent further peroxidation. Here we identify the upregulation of lipopolysaccharide-binding protein (LBP) and its trafficking through LDs as a mechanism for modulating LD homeostasis in response to oxidative stress. Our results suggest that LBP induces lipid accumulation by controlling lipid-redox homeostasis through its lipid-capture activity, sorting unsaturated triglycerides into LDs. N-acetyl-L-cysteine treatment reduces LBP-mediated triglycerides accumulation by phospholipid/triglycerides competition and Peroxiredoxin 4, a redox state sensor of LBP that regulates the shuttle of LBP from LDs. Furthermore, chronic stress upregulates LBP expression, leading to insulin resistance and obesity. Our findings contribute to the understanding of the role of LBP in regulating LD homeostasis and against cellular peroxidative injury. These insights could inform the development of redox-based therapies for alleviating oxidative stress-induced metabolic dysfunction.
Oxidative stress triggers lipid accumulation in cells by sequestering triglycerides in lipid droplets. Here, the authors show that lipopolysaccharide-binding protein interacts with redox sensor PRDX4 to control lipid-redox balance and promotes triglyceride accumulation in droplets by capturing unsaturated lipids.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Science and Technology of China, Laboratory of Diabetes, Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
2 Anhui Medical University, Department of Pathophysiology, Hefei, China (GRID:grid.186775.a) (ISNI:0000 0000 9490 772X)
3 University of Science and Technology of China, Department of Pathology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
4 The First Affiliated Hospital of Anhui University of Chinese Medicine, Department of pathology, Hefei, China (GRID:grid.412679.f) (ISNI:0000 0004 1771 3402)
5 Anhui Medical University, Department of Epidemiology and Biostatistics, School of Public Health, Hefei, China (GRID:grid.186775.a) (ISNI:0000 0000 9490 772X)
6 Anhui Medical University, School of Life Sciences, Hefei, China (GRID:grid.186775.a) (ISNI:0000 0000 9490 772X)
7 University of Science and Technology of China, Department of Chemistry, Center for BioAnalytical Chemistry, Hefei National Laboratory of Physical Science at Microscale, School of Life Sciences, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
8 University of Science and Technology of China, Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
9 Beijing Institute of Lifeomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072)
10 First Affiliated Hospital of Anhui Medical University, Organ Transplantation Center, Department of General Surgery, Hefei, China (GRID:grid.412679.f) (ISNI:0000 0004 1771 3402)
11 First Affiliated Hospital of Anhui Medical University, Department of Respiratory and Critical Care Medicine, Hefei, China (GRID:grid.412679.f) (ISNI:0000 0004 1771 3402)
12 Graduate School of Bengbu Medical College, Bengbu, China (GRID:grid.252957.e) (ISNI:0000 0001 1484 5512)
13 Huazhong University of Science and Technology, Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)